Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
fda - Azithromycin effect on Pseudomonas aeruginosa
GEO DataSets Gene Profile neighbors Chromosome neighbors
fda - Pseudomonas aeruginosa non-mucoid and mucoid strains
fda - Pseduomonas aeruginosa PAO1 response to subinhibitory colistin
fda - Pseudomonas aeruginosa from cystic fibrosis lungs
fda - Azithromycin effect on Pseudomonas aeruginosa PAO1
fda - KinB and RpoN deletion effects on alginate overproduction
fda - Response to low oxygen conditions
fda - Oxidative stress effect on pyocin expression
fda - Pseudomonas aeruginosa response to airway epithelia
fda - Comparison of tobramycin-treated PA14 biofilm/CFBE and planktonic cultures
fda - Iron starvation effect on PA2384 null mutant
fda - Response to copper stress conditions
fda - Uninducible lexA mutant response to ciprofloxacin: time course
fda - Antibiotic-resistant Small Colony Variant
fda - Strain PAO1 response to natural quorum sensing inhibitor protoanemonin
fda - PA2449 deficiency effect on Pseudomonas aeruginosa PAO1
fda - Isolates from burn wound patients
fda - Pseudomonas aeruginosa response to 3,4-(di)hydroxy-heptyl-quinoline: time course
fda - Isolates from chronically-infected burn wound and cystic fibrosis patients
fda - Artificial medium mimicking cystic fibrosis lung sputum
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on